Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

219.400
+6.2002.91%
Volume:2.99M
Turnover:649.43M
Market Cap:338.31B
PE:147.24
High:219.400
Open:215.200
Low:214.400
Close:213.200
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:0.87
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.490
ROE:14.66%
ROA:7.46%
PB:8.34
PE(LYR):147.24
PS:7.04

Loading ...

Movement Alert|BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang

Market Focus
·
Jun 30

Movement Alert|BeOne Medicines Rises 3.01% in Regular Trading, Rebounding After Tax Payment Overhang Digested

Market Focus
·
Jun 29

BeOne Medicines Unit to Pay Additional Income Tax

MT Newswires Live
·
Jun 26

BEIGENE Subsidiary to Pay Approximately 446 Million Yuan in Back Taxes, No Penalty Involved

Stock News
·
Jun 26

BeOne Medicines to Pay RMB446 Million Tax Adjustment, Expense Slated for FY2026

Bulletin Express
·
Jun 26

Movement Alert|BeiGene Rises 3.05% in Regular Trading, Tevimbra Esophageal Cancer Indication FDA Filing Acceptance Continues to Catalyze

Market Focus
·
Jun 24

Movement Alert|BeOne Medicines Rises 3.04% in Regular Trading, FDA Acceptance of Tevimbra Esophageal Cancer Application Continues to Catalyze Rebound

Market Focus
·
Jun 23

Movement Alert|BeOne Medicines Falls 3.05% in Regular Trading, Trading at 157.2 HKD

Market Focus
·
Jun 22

BeiGene grants options, RSUs and PSUs for 21.58 million underlying shares, equal to 1.4% of share capital

Bulletin Express
·
Jun 18

BEIGENE Announces Grant of Share Options, Restricted Share Units, and Performance Share Units

Stock News
·
Jun 18

Movement Alert|BeiGene Rises 3.05% in Regular Trading, Tevimbra Esophageal Cancer Application Accepted by FDA

Market Focus
·
Jun 18

BeOne Medicines (formerly BeiGene) Releases 2026 Company Information Sheet, Details Swiss Redomicile, 16 HKEX Waivers and Ongoing U.S. GAAP Reporting

Bulletin Express
·
Jun 11

Movement Alert|BeOne Medicines Falls 4.17% in Regular Trading, Major Shareholder Reduction and Sustained Innovative Drug Sector Pressure

Market Focus
·
Jun 11

Movement Alert|BeiGene Falls 3.13% in Regular Trading, Major Shareholder Reduction and Innovative Drug Sector Pressure Persist

Market Focus
·
Jun 09

BeiGene Grants 42,648 ADS Restricted Share Units to 381 Employees, Equal to 0.04% of Total Share Capital

Bulletin Express
·
Jun 05

BEIGENE Announces Grant of Restricted Share Units

Stock News
·
Jun 05

Movement Alert|BeiGene Falls 3.1% in Regular Trading, Major Shareholder Reduction and Biotech Sector Weakness Weigh on Shares

Market Focus
·
Jun 05

Movement Alert|BeiGene Rises 4.18% in Regular Trading, Technical Rebound After Consecutive Declines Combined With New Drug Approval Boost

Market Focus
·
Jun 04

Movement Alert|BeiGene Falls 3.02% in Regular Trading, Senior Executive Stake Reduction Combined with Prolonged Innovative Drug Sector Correction

Market Focus
·
Jun 03

Movement Alert|BeOne Medicines Falls 3.85% in Regular Trading, Major Shareholder Reduction Coupled with Prolonged Biotech Sector Weakness

Market Focus
·
Jun 02